| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |